SOMAÍ Pharmaceuticals is a leading EU-GMP vertically integrated Multi-Country Operator (MCO) specialising in the manufacturing of high-quality medical-grade cannabis products. With a focus on transformative treatments, SOMAÍ harnesses the power of the plant to alleviate chronic conditions. The company boasts a global footprint of distribution for its advanced EU GMP-certified cannabinoid-containing pharmaceutical extract portfolio. SOMAÍ envisions a world where individuals can lead healthy lifestyles empowered by natural cannabis medicine.

Services include:
– APIs (Active Pharmaceutical Ingredients)
– Contract Development and Manufacturing (CDMO)
– Finished Dosage Forms

SOMAÍ Pharmaceuticals is committed to building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. For more information, please visit somaipharma.eu.